Charles River Laboratories (CRL) Tops Q3 EPS by 9c; Boosts FY13 Outlook

October 29, 2013 4:41 PM

Charles River Laboratories (NYSE: CRL) reported Q3 EPS of $0.79, $0.09 better than the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found